Cargando…

Amyloid-Driven Tau Accumulation on Mitochondria Potentially Leads to Cognitive Deterioration in Alzheimer’s Disease

Despite the well-accepted role of the two main neuropathological markers (β-amyloid and tau) in the progression of Alzheimer’s disease, the interaction and specific contribution of each of them is not fully elucidated. To address this question, in the present study, an adeno-associated virus (AAV9)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuadrado-Tejedor, Mar, Pérez-González, Marta, Alfaro-Ruiz, Rocío, Badesso, Sara, Sucunza, Diego, Espelosin, María, Ursúa, Susana, Lachen-Montes, Mercedes, Fernández-Irigoyen, Joaquín, Santamaria, Enrique, Luján, Rafael, García-Osta, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584544/ https://www.ncbi.nlm.nih.gov/pubmed/34769380 http://dx.doi.org/10.3390/ijms222111950

Ejemplares similares

Docosahexaenoic Acid Ameliorates Contextual Fear Memory Deficits in the Tg2576 Alzheimer’s Disease Mouse Model: Cellular and Molecular Correlates
por: Badesso, Sara, et al.
Publicado: (2022)

Dysregulated Brain Protein Phosphorylation Linked to Increased Human Tau Expression in the hTau Transgenic Mouse Model
por: Ferrer, Isidro, et al.
Publicado: (2022)

Improvement of cognitive function in wild-type and Alzheimer´s disease mouse models by the immunomodulatory properties of menthol inhalation or by depletion of T regulatory cells
por: Casares, Noelia, et al.
Publicado: (2023)

Proteomics Insights Into the Molecular Basis of SARS-CoV-2 Infection: What We Can Learn From the Human Olfactory Axis
por: Lachén-Montes, Mercedes, et al.
Publicado: (2020)

Tackling the Biological Meaning of the Human Olfactory Bulb Dyshomeostatic Proteome across Neurological Disorders: An Integrative Bioinformatic Approach
por: Cartas-Cejudo, Paz, et al.
Publicado: (2021)

Progressive modulation of the human olfactory bulb transcriptome during Alzheimer´s disease evolution: novel insights into the olfactory signaling across proteinopathies
por: Lachen-Montes, Mercedes, et al.
Publicado: (2017)

Sex-divergent effects on the NAD+-dependent deacetylase sirtuin signaling across the olfactory–entorhinal–amygdaloid axis in Alzheimer’s and Parkinson’s diseases
por: Cartas-Cejudo, Paz, et al.
Publicado: (2023)

Olfactory Bulb Proteomics Reveals Widespread Proteostatic Disturbances in Mixed Dementia and Guides for Potential Serum Biomarkers to Discriminate Alzheimer Disease and Mixed Dementia Phenotypes
por: Lachén-Montes, Mercedes, et al.
Publicado: (2021)

Identifying the Main Functional Pathways Associated with Cognitive Resilience to Alzheimer’s Disease
por: Pérez-González, Marta, et al.
Publicado: (2021)

Proteomic Characterization of the Olfactory Molecular Imbalance in Dementia with Lewy Bodies
por: Lachén-Montes, Mercedes, et al.
Publicado: (2020)

Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy
por: Martier, Raygene, et al.
Publicado: (2019)

Amyotrophic Lateral Sclerosis Is Accompanied by Protein Derangements in the Olfactory Bulb-Tract Axis
por: Lachén-Montes, Mercedes, et al.
Publicado: (2020)

Network-Driven Proteogenomics Unveils an Aging-Related Imbalance in the Olfactory IκBα-NFκB p65 Complex Functionality in Tg2576 Alzheimer’s Disease Mouse Model
por: Palomino-Alonso, Maialen, et al.
Publicado: (2017)

Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer’s disease progression
por: Lachén-Montes, Mercedes, et al.
Publicado: (2017)

Neuroanatomical Quantitative Proteomics Reveals Common Pathogenic Biological Routes between Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
por: Iridoy, Marina Oaia, et al.
Publicado: (2018)

Current Animal Models of Alzheimer’s Disease: Challenges in Translational Research
por: Cuadrado-Tejedor, Mar, et al.
Publicado: (2014)

Convergence of Amyloid-β and Tau Pathologies on Mitochondria In Vivo
por: Eckert, Anne, et al.
Publicado: (2010)

Metabolic dyshomeostasis induced by SARS-CoV-2 structural proteins reveals immunological insights into viral olfactory interactions
por: Lachén-Montes, Mercedes, et al.
Publicado: (2022)

Early-Onset Molecular Derangements in the Olfactory Bulb of Tg2576 Mice: Novel Insights Into the Stress-Responsive Olfactory Kinase Dynamics in Alzheimer’s Disease
por: Lachen-Montes, Mercedes, et al.
Publicado: (2019)

Host Tau Genotype Specifically Designs and Regulates Tau Seeding and Spreading and Host Tau Transformation Following Intrahippocampal Injection of Identical Tau AD Inoculum
por: Andrés-Benito, Pol, et al.
Publicado: (2022)

Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy
por: Ferrer, Isidro, et al.
Publicado: (2020)

Cannabis Use Induces Distinctive Proteomic Alterations in Olfactory Neuroepithelial Cells of Schizophrenia Patients
por: Barrera-Conde, Marta, et al.
Publicado: (2021)

Deregulated Transcription and Proteostasis in Adult mapt Knockout Mouse
por: Andrés-Benito, Pol, et al.
Publicado: (2023)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
por: Mattsson‐Carlgren, Niklas, et al.
Publicado: (2021)

Amyloid-Beta Interaction with Mitochondria
por: Pagani, Lucia, et al.
Publicado: (2011)

Interactions between amyloid, amyloid precursor protein, and mitochondria
por: Wilkins, Heather M.
Publicado: (2023)

Olfactory Characterization and Training in Older Adults: Protocol Study
por: Zambom-Ferraresi, Fabíola, et al.
Publicado: (2021)

Specific Peptide from the Novel W-Tau Isoform Inhibits Tau and Amyloid β Peptide Aggregation In Vitro
por: Cuadros, Raquel, et al.
Publicado: (2022)

Early neurological deterioration, easy methods to detect it
por: Cuadrado-Godia, Elisa
Publicado: (2015)

Mitochondria, Amyloid β, and Alzheimer's Disease
por: Readnower, Ryan D., et al.
Publicado: (2011)

Insights into Disease-Associated Tau Impact on Mitochondria
por: Szabo, Leonora, et al.
Publicado: (2020)

Olfactory proteotyping: towards the enlightenment of the neurodegeneration
por: Fernández-Irigoyen, Joaquín, et al.
Publicado: (2019)

The Amyloid-Tau-Neuroinflammation Axis in the Context of Cerebral Amyloid Angiopathy
por: Cisternas, Pablo, et al.
Publicado: (2019)

Transcriptional Signatures of Tau and Amyloid Neuropathology
por: Castanho, Isabel, et al.
Publicado: (2020)

Membrane-induced tau amyloid fibrils
por: El Mammeri, Nadia, et al.
Publicado: (2023)

Relationship between amyloid and tau levels and its impact on tau spreading
por: Doré, Vincent, et al.
Publicado: (2021)

Assessment of tau phosphorylation and β‐amyloid pathology in human drug‐resistant epilepsy
por: Aroor, Alisha, et al.
Publicado: (2023)

New Insights in the Amyloid-Beta Interaction with Mitochondria
por: Spuch, Carlos, et al.
Publicado: (2012)

Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition
por: Risacher, Shannon L., et al.
Publicado: (2019)

Amyloid‐dependent and amyloid‐independent effects of Tau in individuals without dementia
por: Therriault, Joseph, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_huvduo854jaaeujbn5ogchtlee